The Effect of “High Fibre Biscuits” on Urinary Risk Factors for Stone Formation

  • P. N. Rao
  • I. L. Jenkins
  • W. G. Robertson
  • M. Peacock
  • N. J. Blacklock


Idiopathic hypercalciuria is a common finding in stone formers1−3. Conversely, a reduction in urinary calcium decreases the recurrence rate of stone formation4. Excessive absorption of calcium from the intestine is the major cause of hypercalciuria5, but an increased consumption of fibre may reduce urinary calcium3,6 by binding calcium in the gut. If this is the mechanism by which fibre reduces urinary calcium, however, there is the risk that more oxalate might become available for passive absorption. This may produce marginal hyperoxaluria, as in the case of other calcium-binding agents, such as cellulose phosphate7. The most common form of fibre supplement is cereal bran which contains a variable quantity of oxalate. It is not known if this oxalate is “available” for absorption.


Uric Acid Urinary Calcium Excretion Urinary Oxalate Idiopathic Hypercalciuria Fibre Supplement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    W. G. Robertson, M. Peacock, P. J. Heyburn, D. H. Marshall, and P. B. Clark, Br. J. Urol. 50:449 (1978).PubMedCrossRefGoogle Scholar
  2. 2.
    G. A. Rose and A. R. Harrison, Br. J. Urol. 46:261 (1974).PubMedCrossRefGoogle Scholar
  3. 3.
    P. N. Rao, V. Prendiville, A. Buxton, D. G. Moss, and N. J. Blacklock, Br. J. Urol. 54:578 (1982).PubMedCrossRefGoogle Scholar
  4. 4.
    P. J. Heyburn, W. G. Robertson, and M. Peacock, Nephron 32:314 (1982).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Peacock, F. Knowles, and B. E. C. Nordin, Br. Med. J. 2:729 (1968).PubMedCrossRefGoogle Scholar
  6. 6.
    P. J. R. Shah, G. Williams, and N. A. Green, Br. J. Urol. 52:426 (1980).PubMedCrossRefGoogle Scholar
  7. 7.
    C. Y. C. Pak, Invest. Urol. 19:187 (1981).PubMedGoogle Scholar
  8. 8.
    M. Fuss, D. Verbeelen, J. Geurts, J. Simon, A. Bergans, M. De Backer, R. Six, and J. Coruilain, Eur. Urol. 4:324 (1978).Google Scholar
  9. 9.
    A. Hodgkinson and A. Williams, Clin. Chim. Acta 36:127 (1972).PubMedCrossRefGoogle Scholar
  10. 10.
    M. MacLeod, J. Roy. Nav. Med. Ser. 57:88 (1971).Google Scholar
  11. 11.
    G. B. Haber, K. W. Heaton, and D. Murphy, Lancet 2:679 (1977).PubMedCrossRefGoogle Scholar
  12. 12.
    P. N. Rao, C. Gordon, D. Davies, and N. J. Blacklock, Br. J.Urol. 54:575 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • P. N. Rao
    • 1
  • I. L. Jenkins
    • 1
  • W. G. Robertson
    • 1
  • M. Peacock
    • 1
  • N. J. Blacklock
    • 2
  1. 1.Depts. of UrologyUniversity Hospital of South ManchesterManchesterUK
  2. 2.The General InfirmaryRoyal Naval Hospital Haslar and MRC Mineral Metabolism UnitLeedsUK

Personalised recommendations